PARP1 and Nephropathy: PARPi may cause the greatest radiosensitisation effect but their clinical potential may be greatest in combination with cisplatin because we show conclusively that cisplatin-induced kidney damage is due to PARP activation and that PARP inhibition can ameliorate kidney injury, which is dose limiting for use of cisplatin.